Guided Therapeutics (GTHP) Revenue Growth (5y) (2015 - 2025)
Guided Therapeutics (GTHP) Revenue Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.06 Bn | 175.76 Bn | 6.27 Bn |
| 2 | Stryker | 128.66 Bn | 125.78 Bn | 3.81 Bn |
| 3 | Medtronic | 108.82 Bn | 99.60 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.43 Bn | 66.98 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.29 Bn | 44.61 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.37 Bn | 26.08 Bn | 1.98 Bn |
| 7 | Dexcom | 28.29 Bn | 27.18 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.31 Bn | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn |
| 10 | Guided Therapeutics | 20.39 Mn | 20.32 Mn | 458,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 88.18% |
| Sep 30, 2025 | -4.87% |
| Dec 31, 2024 | -42.57% |
| Mar 31, 2024 | -19.73% |
| Dec 31, 2023 | -5.29% |
| Jun 30, 2023 | 40.63% |
| Mar 31, 2023 | 40.63% |
| Sep 30, 2022 | -38.10% |
| Jun 30, 2022 | -43.52% |
| Mar 31, 2022 | -24.95% |
| Dec 31, 2021 | 16.25% |
| Sep 30, 2021 | -27.52% |
| Dec 31, 2020 | 22.67% |
| Sep 30, 2020 | 57.28% |
| Dec 31, 2019 | 4.24% |
| Sep 30, 2019 | -46.11% |
| Jun 30, 2019 | -38.10% |
| Mar 31, 2019 | -1.08% |
| Dec 31, 2018 | -34.41% |
| Sep 30, 2018 | -52.87% |